InvestorsHub Logo
Followers 151
Posts 15834
Boards Moderated 1
Alias Born 03/01/2005

Re: DewDiligence post# 122

Friday, 02/07/2020 1:18:03 PM

Friday, February 07, 2020 1:18:03 PM

Post# of 254
well I still evolus has a better chance than Revance due to doctor is changing fees for injections. its more appealing repeat business more frequently than once a year.

I just wish this lawsuit would be finished. FDA rejected Allergan. If it's the same arguments should be the same outcome
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent EOLS News